| 1 |
What is the primary function of AI in the medical imaging industry?
|
To improve diagnostic accuracy and patient outcomes |
|
Because AI helps detect diseases faster and more precisely by analyzing images, which leads to better diagnoses and treatment decisions. |
Based on numerous studies and reviews in medical imaging literature highlighting AI’s role in enhancing diagnostic performance and patient care. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 2 |
Which of the following is a key benefit of AI in radiology noted in the article?
|
Acts as a second medical opinion |
|
Because AI assists radiologists by providing an additional, unbiased analysis to improve diagnostic confidence and reduce errors. |
Based on the article’s emphasis on AI serving as a supportive tool that complements human expertise in radiology. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 3 |
What does AI literacy refer to according to the article?
|
Understanding and knowledge of AI technology |
|
Because AI literacy means being able to comprehend how AI works, its applications, and implications not just technical repair or legal/financial aspects. |
Based on the article’s definition focusing on users and professionals grasp of AI concepts and technology. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 4 |
Which factor is NOT listed as influencing the acceptability of AI among healthcare professionals?
|
The color of the AI machines |
|
Because things like trusting the AI, understanding how it works, and how well it fits into their daily work really matter. The color of the machine doesn’t affect whether they accept AI. |
From studies that show healthcare workers care about how useful and easy AI is, not how it looks. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 5 |
What role does social influence play in AI acceptability in healthcare according to the article?
|
Affects healthcare professionals’ decisions to use AI |
|
Because the opinions and behaviors of colleagues and leaders can make healthcare workers more or less willing to use AI in their work. |
Based on research showing that social pressure and support influence how new technology like AI gets accepted in healthcare settings. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 6 |
What is a perceived threat regarding AI usage in healthcare settings?
|
Concerns about replacing healthcare professionals |
|
Because many people worry that AI might take over tasks or jobs done by doctors and nurses, which makes them feel threatened. |
Based on studies showing that healthcare workers often fear AI could replace them, even though AI is meant to help, not replace. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 7 |
According to the article, what is essential for increasing AI acceptability among medical professionals?
|
Designing human-centred AI systems |
|
Because AI that focuses on helping people and fits well with how doctors work is more likely to be accepted than systems that don’t consider users. |
Based on the article highlighting the importance of making AI easy to use and tailored to medical professionals needs. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 8 |
What does the 'system usage' category of AI acceptability factors include according to the article?
|
Factors like value proposition and integration with workflows |
|
Because ‘system usage’ means how useful the AI is and how well it fits into doctors daily work routines, not personal preferences or location. |
Based on the article explaining that system usage covers how AI adds value and works smoothly with existing healthcare processes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 9 |
How does ethicality impact AI acceptability among healthcare professionals?
|
Affects views on AI based on compatibility with professional values |
|
Because healthcare workers want AI to follow medical ethics and respect patient care values, which makes them more likely to accept it. |
Based on research showing that ethical concerns influence how professionals trust and use AI in healthcare. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 10 |
What methodological approach did the article emphasize for future AI acceptability studies?
|
Considering user experience and system integration deeply |
|
Because understanding how users interact with AI and how it fits into their daily work is key to making AI more acceptable and useful.
|
Based on the article’s recommendation to focus on real-world use and user needs rather than just technical or economic factors. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 11 |
What is the primary objective of using human embryonic stem cells in treating Parkinson’s disease?
|
To replace lost dopamine neurons. |
|
Because Parkinson’s disease causes the loss of dopamine-producing neurons, so the main goal of stem cell therapy is to restore these specific cells to improve symptoms. |
Based on scientific research and clinical studies focusing on stem cell therapy aimed at replacing damaged dopamine neurons in Parkinson’s patients. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 12 |
Which animal was used to test the STEM-PD product for safety and efficacy?
|
Monkeys |
|
Because monkeys have brain structures more similar to humans, making them suitable for testing treatments like STEM-PD before human trials.
|
Based on preclinical studies that often use non-human primates to evaluate safety and effectiveness of Parkinson’s therapies. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 13 |
What was the duration of the preclinical safety study in rats mentioned in the article?
|
6 months |
|
Because the article specified a 6-month period to observe long-term safety effects before moving to clinical trials.
|
Based on the study details describing a 6-month preclinical evaluation in rats for safety assessment. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 14 |
What is the name of the clinical trial phase mentioned for STEM-PD?
|
Phase I/IIa |
|
Because this combined phase tests both safety (Phase I) and early effectiveness (Phase IIa) of STEM-PD in patients. |
Based on the article describing the ongoing clinical trial phase for STEM-PD as Phase I/IIa. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 15 |
How is the STEM-PD product manufactured?
|
Under GMP-compliant conditions |
|
Because good manufacturing practice (GMP) ensures the product is made safely, consistently, and meets quality standards required for clinical use.
|
Based on the article stating STEM-PD is produced following GMP-compliant manufacturing processes. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 16 |
According to the article, what confirmed the safety of the STEM-PD product in rats?
|
There were no adverse effects or tumor formation. |
|
Because absence of negative effects and tumors shows the product is safe for further testing.
|
Based on the preclinical study results reported in the article confirming safety in rat models. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 17 |
What key finding was noted in the efficacy study of STEM-PD in rats?
|
Transplanted cells reversed motor deficits in rats. |
|
Because the goal of STEM-PD is to restore lost function, and the study showed improvement in motor symptoms after treatment.
|
Based on the article’s preclinical results demonstrating functional recovery in rat models of Parkinson’s disease. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 18 |
What specific markers were used to assess the purity of the STEM-PD batch?
|
LMX1A and EN1 |
|
Because LMX1A and EN1 are key transcription factors that indicate the cells are developing into the correct midbrain dopamine neuron lineage.
|
Based on the article detailing marker analysis confirming cell purity in the STEM-PD manufacturing process. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 19 |
What role do growth factors like FGF8b and SHH play in the manufacturing process of STEM-PD?
|
They are used in cell patterning for specific neural fates. |
|
Because FGF8b and SHH guide stem cells to develop into specific types of neurons, like the dopamine neurons needed for Parkinson’s therapy.
|
Based on the article explaining how these growth factors help direct stem cell differentiation during STEM-PD production. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|
| 20 |
What was a key outcome measured in the preclinical trials for efficacy in rats?
|
Recovery of motor function |
|
Because Parkinson’s disease mainly affects movement, so improving motor skills shows the treatment works.
|
Based on the preclinical study results focusing on motor function recovery in rat models after STEM-PD treatment. |
7 |
-.50
-.25
+.25
เต็ม
0
-35%
+30%
+35%
|